Impulsive and compulsive behaviors can be induced by opposite GABAergic dysfunctions inside the primate ventral pallidum

被引:2
|
作者
Saga, Yosuke [1 ]
Galineau, Laurent [2 ]
Tremblay, Leon [1 ,3 ]
机构
[1] CNRS, Inst Sci Cognit Marc Jeannerod, UMR 5229, Bron, France
[2] Univ Francois Rabelais Tours, UMR INSERM U1253, Tours, France
[3] Univ Claude Bernard Lyon 1, Villeurbanne, France
基金
日本学术振兴会; 瑞士国家科学基金会;
关键词
non-human primate; anterior pallidum; muscimol; bicuculline; anxiety behavior; hyperactivity state; GABA NEURONS; ACTIVATION; ANTICIPATION; MODULATION; ACCUMBENS; GLUTAMATE; STRIATUM; MOVEMENT; NUCLEUS; PATHWAY;
D O I
10.3389/fnsys.2022.1009626
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Introduction: The ventral pallidum (VP) is central in the limbic Basal Ganglia circuit, controlling both appetitive (approach) and aversive (avoidance) motivated behaviors. Nevertheless, VP involvement in pathological aspects remains unclear, especially in the behavioral expression of different motivational dysfunctions. This study aimed to investigate how the VP contributes to the expression of abnormal behaviors via opposite GABAergic dysfunctions.Methods: Opposite GABAergic dysfunctions were induced by injecting muscimol (a GABA(A) agonist) and bicuculline (a GABA(A) antagonist) into monkeys. We determined the effects of both substances on self-initiated behaviors in lab-chair and in free-moving home-cage contexts in six monkeys, and in two animals performing an approach-avoidance task in appetitive and aversive contexts.Results: While the self-initiated behaviors induced by bicuculline injections in VP were characterized by compulsive behaviors such as repetitive grooming and self-biting, muscimol injections induced impulsive behaviors including limb movements in a lab-chair context and exploration behaviors in a free-moving context. More specific behavioral effects were observed in the approach-avoidance task. The muscimol injections induced premature responses and erroneous screen touches, which characterize impulsive and attention disorders, while the bicuculline injections into the VP increased passive avoidance (non-initiated action) and task-escape in an aversive context, suggesting an anxiety disorder.Conclusions: These results show that activating or blocking GABAergic transmission in the VP impairs motivated behaviors. Furthermore, the behavioral expressions produced by these opposite disturbances show that the VP could be involved in anxiety-driven compulsive disorders, such as OCD, as well as in impulsive disorders motivated by attention deficits or reward-seeking, as seen in ADHD or impulse control disorders.
引用
收藏
页数:13
相关论文
共 5 条
  • [1] Are impulsive compulsive behaviors associated with levodopa-induced dyskinesia? A Brazilian cross-sectional study
    Veiga, Beatriz A. Anjos G.
    da Silva, Carolina Candeias
    Saba, Roberta Arb
    Silva, Sonia Maria C. A.
    Ferraz, Henrique Ballalai
    Borges, Vanderci
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2025, 249
  • [2] A Network Analysis shows How Impulsive-Compulsive Behaviors correlates with Levodopa-Induced Dyskinesia
    Veiga, B.
    Silva, C.
    Silva, S.
    Saba, R.
    Ferraz, H.
    Borges, V.
    MOVEMENT DISORDERS, 2024, 39 : S147 - S148
  • [3] GABAERGIC PROJECTION FROM NUCLEUS-ACCUMBENS TO VENTRAL PALLIDUM MEDIATES DOPAMINE-INDUCED SENSORIMOTOR GATING DEFICITS OF ACOUSTIC STARTLE IN RATS
    SWERDLOW, NR
    BRAFF, DL
    GEYER, MA
    BRAIN RESEARCH, 1990, 532 (1-2) : 146 - 150
  • [4] Motivational and myopic mechanisms underlying dopamine medication-induced impulsive-compulsive behaviors in Parkinson's disease
    Dawson, Andrew
    Ortelli, Paola
    Carter, Adrian
    Ferrazzoli, Davide
    Dissanayaka, Nadeeka N.
    Evans, Andrew
    Chye, Yann
    Lorenzetti, Valentina
    Frazzitta, Giuseppe
    Yucel, Murat
    FRONTIERS IN BEHAVIORAL NEUROSCIENCE, 2023, 16
  • [5] Histamine and its H1 receptors in the ventral pallidum mediate formalin-induced pain-related behaviors through this region and spinal cord opioid receptors
    Asgharieh-Ahari, Morteza
    Tamaddonfard, Esmaeal
    Erfanparast, Amir
    Soltanalinejad-Taghiabad, Farhad
    BEHAVIOURAL PHARMACOLOGY, 2023, 34 (08): : 457 - 467